Biovail Settles Securities Suit For $138M
Under the terms of the agreement, the total amount payable to the class will be $138 million. However, Biovail estimated that it would ultimately pay only about $85 million after the resolution of all insurance claims.
Neither the Toronto-based company nor any of the individual defendants named in the suit admitted...
To view the full article, register now.